One Load valued at around R $ 1 million of the drug Mounjaro indicated for the treatment of diabetes and commonly used for weight loss, was retained in an action of the Federal Police at Recife International Airport at dawn on Sunday (13).
About 389 pens of the drug were intercepted by the Revenue Province during risk analysis and passenger monitoring work. The organ identified that a traveler coming from the UK carried the medicines irregularly.
The inspection was carried out at the time of the arrival of the passenger, as part of the customs control routine. The action is part of the activities aimed at combating smuggling and misleading crimes.
What is Mounjaro
Mounjaro, Diabetes Medicine at Eli Lilly, will be available in the Brazilian market from June 7th.
Considered the main competitor of Ozempic and Wegovy, both of the New Danish Pharmacist Nordisk, the drug is composed of thiepatit, a double agonist molecule of GLP-1 and GIP, hormones generated in the intestine and released after meals, increasing insulin production by the pancreas to maintain blood sugar control.
Mounjaro was approved by the National Health Surveillance Agency (Anvisa) in Brazil in September 2023 for the treatment of type 2 diabetes.
“There are already other medicines in Brazil of the same class, but Mounjaro has a different mechanism of action, because it is not just an agonist, that is, it does not only act on the GLP-1 receiver, it also acts on the GIP receiver. He is the only medicine of this class that acts on these two receptors,” explains Luiz Magno, senior medical director of Eli Lilly do Brasil, to CN.
According to Tassiane Alvarenga, an endocrinologist and metabologist from USP (University of São Paulo), both GIP and GLP-1 are linked to greater insulin secretion, but studies lead to believe that the GIP responds for about two thirds of this contribution. This makes the tirzepatida more powerful than the semaglutado, present in Ozempic.
“Mounjaro induces the feeling of satiety, that is, the time between eating and being satisfied. It is a more lasting effect than the loss of appetite, which is the main feature of Ozepic,” explains the endocrinologist.
The drug should be used to treat diabetes associated with lifestyle changes, such as the adoption of healthy eating and the practice of physical activity. Remember that the Mounjaro is not approved for the treatment of obesity And yes, only for type 2 diabetes.
The value of the medicine may vary depending on the tax on the circulation of goods and the provision of services (ICMS) in each state, the dose and the number of pens for application per pack. For example, in São Paulo, the maximum dose may cost R $ 3,791.07.
Side effects
According to a study published in The New England Journal of Medicine, he showed that both Tirzepatida and Semaglute has similar side effects but the effects of the first molecule can be more numerous and more serious. According to work, Mounjaro can cause severe gastrointestinal diseases. In clinical trials, more people stopped taking the drug due to gastrointestinal side effects.
Both medications can cause symptoms such as abdominal pain, constipation, diarrhea, nausea and vomiting. Tirzepatida can also cause indigestion.
That’s why, It is essential to seek medical advice before starting treatment whether with Ozepic, with Monjauro.
*Under supervision
This content was originally published in a cargo of $ 1 million in Mounjaro is seized at Recife airport on CNN Brazil.
Source: CNN Brasil
I’m James Harper, a highly experienced and accomplished news writer for World Stock Market. I have been writing in the Politics section of the website for over five years, providing readers with up-to-date and insightful information about current events in politics. My work is widely read and respected by many industry professionals as well as laymen.
